中商官网
研究报告
复星医药（HK2196）
| 科目\年度 | 2025-06-30 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
原始货币 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 审计意见 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 报表核心指标 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 税后利润 |
210021.00 | 351244.00 | 290740.40 | 395363.40 | 497626.90 | 393998.10 | 374352.20 | 301988.20 | 358525.90 | 322134.20 | 287066.10 | 236983.90 | 195545.10 | 183927.10 |
| 营业收入 |
1942553.00 | 4090988.00 | 4124851.00 | 4381139.00 | 3886418.00 | 3016326.00 | 2838928.00 | 2471388.00 | 1836161.00 | 1450558.00 | 1250216.00 | 1193824.00 | 992148.70 | 727828.70 |
| 销售成本 |
1012346.00 | 2136557.00 | 2159531.00 | 2316969.00 | 2022979.00 | 1373353.00 | 1154342.00 | 1036531.00 | 760895.30 | 671836.40 | 630804.10 | 671856.90 | 554336.90 | 412680.40 |
| 税前利润 |
271848.10 | 416928.10 | 327690.80 | 458055.20 | 604267.00 | 467784.60 | 452575.30 | 357959.30 | 406171.70 | 357154.90 | 337183.20 | 271805.30 | 231360.90 | 212303.50 |
| 归属于母公司股东利润 |
170196.70 | 276988.60 | 239755.60 | 373697.50 | 472871.10 | 366281.30 | 332161.80 | 270792.30 | 312418.30 | 280485.20 | 245939.90 | 211180.70 | 158256.10 | 156391.60 |
| 营业收入 |
1942553.00 | 4090988.00 | 4124851.00 | 4381139.00 | 3886418.00 | 3016326.00 | 2838928.00 | 2471388.00 | 1836161.00 | 1450558.00 | 1250216.00 | 1193824.00 | 992148.70 | 727828.70 |
| 其中：营业额 |
1942553.00 | 4090988.00 | 4124851.00 | 4381139.00 | 3886418.00 | 3016326.00 | 2838928.00 | 2471388.00 | 1836161.00 | 1450558.00 | 1250216.00 | 1193824.00 | 992148.70 | 727828.70 |
| 销售成本 |
1012346.00 | 2136557.00 | 2159531.00 | 2316969.00 | 2022979.00 | 1373353.00 | 1154342.00 | 1036531.00 | 760895.30 | 671836.40 | 630804.10 | 671856.90 | 554336.90 | 412680.40 |
| 毛利 |
930206.80 | 1954430.00 | 1965320.00 | 2064170.00 | 1863439.00 | 1642973.00 | 1684586.00 | 1434857.00 | 1075266.00 | 778722.00 | 619412.20 | 521967.40 | 437811.80 | 315148.30 |
| 加：其他收入 |
137362.20 | 148184.40 | 191698.70 | 320420.30 | 369810.90 | 169901.50 | 223368.90 | 112643.20 | 119245.80 | 101518.40 | 134535.30 | 136440.40 | 91066.70 | 115509.80 |
| 减：销售费用 |
421106.30 | 867976.40 | 971223.60 | 917117.60 | 910080.30 | 816159.20 | 984675.70 | 848753.30 | 579053.60 | 370405.60 | 281514.10 | 230042.40 | 184353.40 | 151228.60 |
| 管理费用 |
384062.00 | 808433.70 | 884117.30 | 821783.30 | 715164.60 | 583160.30 | 469614.40 | 377049.10 | 280033.20 | 234116.40 | 190552.20 | 172681.90 | 142063.80 | 104565.20 |
| 财务费用 |
48932.60 | 105870.50 | 96118.59 | 68117.20 | 58875.50 | 68134.30 | 88804.20 | 78392.00 | 49831.70 | 40727.20 | 41376.50 | 34527.60 | 28660.50 | 34090.30 |
| 其他费用 |
31712.70 | 56726.90 | 83160.10 | 296494.20 | 116374.50 | 25186.10 | 45714.90 | 17529.60 | 14553.40 | 12117.10 | 14068.20 | 40395.60 | 19609.60 | 9283.80 |
| 经营溢利特殊科目 |
-2873.40 | -11063.10 | -13192.70 | -6536.90 | -7401.60 | -10483.60 | -9711.40 | -2716.20 | -- | -- | -- | -- | -- | -- |
| 经营溢利 |
178882.00 | 252544.20 | 109205.90 | 274540.60 | 425353.30 | 309751.10 | 309433.90 | 223059.60 | 271039.40 | 222874.10 | 226436.50 | 180760.30 | 154191.20 | 131490.20 |
| 加：应占联营公司业绩 |
93413.90 | 182824.80 | 238687.90 | 206907.10 | 203652.50 | 171359.20 | 149601.30 | 139943.80 | 136684.80 | 134168.10 | 111851.60 | 92914.80 | 78246.20 | 80964.70 |
| 应占共同控制实体业绩 |
-447.80 | -18440.90 | -20203.00 | -23392.50 | -24738.80 | -13325.70 | -6459.90 | -5044.10 | -1552.50 | 112.70 | -1104.90 | -1869.80 | -1076.50 | -151.40 |
| 税前利润 |
271848.10 | 416928.10 | 327690.80 | 458055.20 | 604267.00 | 467784.60 | 452575.30 | 357959.30 | 406171.70 | 357154.90 | 337183.20 | 271805.30 | 231360.90 | 212303.50 |
| 减：所得税费用 |
61827.10 | 65684.10 | 36950.40 | 62691.80 | 106640.10 | 73786.50 | 78223.09 | 55971.10 | 47645.80 | 35020.70 | 50117.10 | 34821.40 | 35815.80 | 28376.40 |
| 税后利润 |
210021.00 | 351244.00 | 290740.40 | 395363.40 | 497626.90 | 393998.10 | 374352.20 | 301988.20 | 358525.90 | 322134.20 | 287066.10 | 236983.90 | 195545.10 | 183927.10 |
| 归属于母公司股东利润 |
170196.70 | 276988.60 | 239755.60 | 373697.50 | 472871.10 | 366281.30 | 332161.80 | 270792.30 | 312418.30 | 280485.20 | 245939.90 | 211180.70 | 158256.10 | 156391.60 |
| 归属于非控制股股东利润 |
39824.30 | 74255.40 | 50879.80 | 21665.90 | 24755.80 | 27716.80 | 42190.40 | 31195.90 | 46075.90 | 41550.50 | 41056.70 | 25697.00 | 37289.00 | 27535.50 |
| 归属于非股东利润 |
-- | -- | 105.00 | -- | -- | -- | -- | -- | 31.70 | 98.50 | 69.50 | 106.20 | -- | -- |
| 基本每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 稀释每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 其他综合收益 |
-3265.90 | 4314.30 | 3185.60 | 10804.30 | -34418.10 | -58984.50 | -21782.60 | -66868.50 | -46596.90 | -7214.00 | -19324.70 | -6768.90 | 39523.00 | -67895.09 |
| 综合收益总额 |
206755.10 | 355558.30 | 293926.00 | 406167.70 | 463208.80 | 335013.60 | 352569.60 | 235119.70 | 311929.00 | 314920.20 | 267741.40 | 230215.00 | 235068.10 | 116032.00 |
| 归属于母公司股东综合收益总额 |
165985.80 | 275365.80 | 236316.40 | 383758.50 | 439645.80 | 311900.00 | 312840.40 | 209938.70 | 269133.80 | 271670.70 | 225847.30 | 205133.80 | 198180.50 | 90077.20 |
| 归属于非控制股股东综合收益总额 |
40769.30 | 80192.50 | 57609.60 | 22409.20 | 23563.00 | 23113.60 | 39729.20 | 25181.00 | 42795.20 | 43249.50 | 41894.10 | 25081.20 | 36887.60 | 25954.80 |